obesity drug news today glp-1 september 22 2025 What to Know About New Weight Loss Pills GLP-1 weight loss drugs leave

Our ipamorelin is synthesised under rigorous quality-controlled manufacturing conditions, verified to a purity of greater than 99% by HPLC and Mass Spectrometry, and supplied as a lyophilised (freeze-dried) powder for maximum stability

Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra

Their effectiveness in sustained weight loss has made them a popular choice in the medical weight loss space

2025 marked major milestones in CNS drug development, with multi-billion-dollar partnerships including AbbVie/Gilgamesh, Novartis/Avidity and Roche/Manifold highlighting robust investment across numerous therapeutic areas